美国 · 平台与数据 · MarketBeat

Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

来源：MarketBeat · 美国 1 小时前

Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

推荐阅读

Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching.

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

Bank of Korea holds rates, upbeat outlook points to future hikes

FUN Stock Heads For 4th Week Of Loss: Analyst Sees 29% Downside Ahead Of Earnings As Mounting Debt, Weak Sales Loom

KFC rolls out 13 days of Halloween deals, but there’s a catch

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

分享

推荐阅读

Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching.

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

Bank of Korea holds rates, upbeat outlook points to future hikes

FUN Stock Heads For 4th Week Of Loss: Analyst Sees 29% Downside Ahead Of Earnings As Mounting Debt, Weak Sales Loom

KFC rolls out 13 days of Halloween deals, but there’s a catch

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge